FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Search Results

Rifapentine Tablets
Status: Currently in Shortage
»Date first posted: 03/25/2020
»Therapeutic Categories: Anti-Infective

Sanofi (Revised 06/22/2021)

Company Contact Information:
800-633-1610 Option 7

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Rifapentine (Piftin) Tablets, 150 mg (NDC 0088-2102-24) Available Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English